Taho Pharmaceuticals Ltd. (TPEX:6467)
228.50
+34.00 (17.48%)
At close: Sep 7, 2026
| Market Cap | 11.98B +23.6% |
| Revenue (ttm) | 1.98M -74.5% |
| Net Income | -238.34M |
| EPS | -4.58 |
| Shares Out | 52.41M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,648,966 |
| Open | 196.00 |
| Previous Close | 194.50 |
| Day's Range | 192.50 - 229.00 |
| 52-Week Range | 100.50 - 228.50 |
| Beta | -0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |